Jim Cramer explains the art and science of technical analysis. Plus, he has next week's game plan.

Here's a technical look at how to trade a number of stocks rising with unusual volume flow.

Phibro Animal Health (PAHC) reported better-than-anticipated results for the 2016 fiscal fourth quarter late Monday.

Trade-Ideas LLC identified Phibro Animal Health (PAHC) as a weak on high relative volume candidate

Stocks with insider trader activity include UBA, PAHC and IDI

Trade-Ideas LLC identified Phibro Animal Health (PAHC) as a new lifetime high candidate

Trade-Ideas LLC identified Phibro Animal Health (PAHC) as a strong and under the radar candidate

Gilead shares have had a tremendous run this year, but the valuation remains cheap considering its sales potential in the area of Hepatitis C.

Phibro Animal Health Corp. (PAHC) rose on Friday, its first day of trading after the animal health pharmaceutical manufacturer's IPO. The company priced 11.765 shares of Class A common stock in its initial public offering at $15 a share, below its $16 to $18 range. U.K. private equity firm 3i Group backed the Teaneck, N.J.-based Phibro, which sold 7.352 million shares in the offering. Selling stockholder Mayflower, which 3i manages, offered the rest of the shares. Phibro opened at $16.50 on Friday and hit a high of $16.75 as of 1:15 p.m. More than 3.3 million shares had changed hands.

U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.

Core retail sales improved firmly in July, but the headline figure was essentially unchanged as gas prices tumbled from their June record highs.

E-commerce giant Amazon is the subject of a major investigation linked to its Prime service. It's not sitting idly by.